Report Overview: The Global Active Implantable Devices Market achieved a valuation of $25.75 Billion in 2022 and is anticipated to exceed $45.24 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 7.3% during the forecast period from 2024 to 2032. Key Market Players: Sonova Holding AG, Medtronic, Abbott, Lifetech Scientific, Boston Scientific Corporation,...